IS7641A - Asýloxýpýrrólidín afleiður og notkun þeirra sem bindlar á V1B eða bæði V1B og V1A viðtaka - Google Patents

Asýloxýpýrrólidín afleiður og notkun þeirra sem bindlar á V1B eða bæði V1B og V1A viðtaka

Info

Publication number
IS7641A
IS7641A IS7641A IS7641A IS7641A IS 7641 A IS7641 A IS 7641A IS 7641 A IS7641 A IS 7641A IS 7641 A IS7641 A IS 7641A IS 7641 A IS7641 A IS 7641A
Authority
IS
Iceland
Prior art keywords
receptors
bind
those
acyloxypyrrolidine
derivatives
Prior art date
Application number
IS7641A
Other languages
English (en)
Other versions
IS2487B (is
Inventor
Aulombard Alain
Garcia Georges
Pradines Antoine
Serradeil-Le Gal Claudine
Wagnon Jean
Original Assignee
Sanofi-Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi-Aventis filed Critical Sanofi-Aventis
Publication of IS7641A publication Critical patent/IS7641A/is
Publication of IS2487B publication Critical patent/IS2487B/is

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06—Antiabortive agents; Labour repressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Pregnancy & Childbirth (AREA)
  • Child & Adolescent Psychology (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Gynecology & Obstetrics (AREA)
  • Anesthesiology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IS7641A 2002-07-19 2005-01-12 Asýloxýpýrrólidín afleiður, framleiðsla og meðferðarnotkun þar á IS2487B (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0209242A FR2842527B1 (fr) 2002-07-19 2002-07-19 Derives d'acyloxypyrolidine, leur preparation et leur application en therapeutique
PCT/FR2003/002262 WO2004009585A2 (fr) 2002-07-19 2003-07-17 Derives d'acyloxypyrrolidine et leur utilisation en tant que ligands des recepteurs v1b et v1a de avp

Publications (2)

Publication Number Publication Date
IS7641A true IS7641A (is) 2005-01-12
IS2487B IS2487B (is) 2008-12-15

Family

ID=29797610

Family Applications (1)

Application Number Title Priority Date Filing Date
IS7641A IS2487B (is) 2002-07-19 2005-01-12 Asýloxýpýrrólidín afleiður, framleiðsla og meðferðarnotkun þar á

Country Status (27)

Country Link
US (1) US7202267B2 (is)
EP (1) EP1525198B1 (is)
JP (1) JP4264414B2 (is)
CN (1) CN100425608C (is)
AR (1) AR040571A1 (is)
AT (1) ATE312092T1 (is)
AU (1) AU2003271815B8 (is)
BR (1) BR0312800A (is)
CA (1) CA2492224A1 (is)
DE (1) DE60302670T2 (is)
DK (1) DK1525198T3 (is)
EA (1) EA008444B1 (is)
ES (1) ES2254962T3 (is)
FR (1) FR2842527B1 (is)
HR (1) HRP20041231A2 (is)
IL (1) IL165942A (is)
IS (1) IS2487B (is)
ME (1) MEP12408A (is)
MX (1) MXPA05000822A (is)
NO (1) NO20050292L (is)
NZ (1) NZ537615A (is)
PL (1) PL375309A1 (is)
RS (1) RS20050018A (is)
TW (1) TWI274751B (is)
UA (1) UA78805C2 (is)
WO (1) WO2004009585A2 (is)
ZA (1) ZA200500478B (is)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7528124B2 (en) 2003-08-28 2009-05-05 Taisho Pharmaceutical Co., Ltd. 1,3-dihydro-2H-indol-2-one derivative
TW200643015A (en) 2005-03-11 2006-12-16 Akzo Nobel Nv 2-(4-oxo-4H-quinazolin-3-yl)acetamide derivatives
DE102005015957A1 (de) * 2005-03-31 2006-10-05 Abbott Gmbh & Co. Kg Substituierte Oxindol-Derivate, diese enthaltende Arzneimittel und deren Verwendung
CA2610400A1 (en) 2005-06-07 2006-12-14 Pharmacopeia, Inc. Azinone and diazinone v3 inhibitors for depression and stress disorders
CN101600698B (zh) 2006-09-11 2012-01-11 欧加农股份有限公司;药典有限责任公司 喹唑啉酮和异喹啉酮乙酰胺衍生物
CN103864658B (zh) * 2014-03-06 2016-06-15 南京工业大学 氮杂环丁酮衍生物及其制备方法与应用
CN104447489B (zh) * 2014-12-29 2017-01-11 南京工业大学 3,4-二芳基马来酰亚胺衍生物及其制备方法与应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2804114B1 (fr) * 2000-01-25 2002-03-08 Sanofi Synthelabo Nouveaux derives de 1,3-dihydro-2h-indol-2-one, un procede pour leur preparation et les compositions pharmaceutiques en contenant

Also Published As

Publication number Publication date
AU2003271815B2 (en) 2009-03-12
RS20050018A (sr) 2007-06-04
IL165942A (en) 2010-04-15
TW200410957A (en) 2004-07-01
JP4264414B2 (ja) 2009-05-20
DE60302670T2 (de) 2006-09-07
AU2003271815A1 (en) 2004-02-09
NZ537615A (en) 2006-11-30
MEP12408A (en) 2010-06-10
CN1681806A (zh) 2005-10-12
JP2005537271A (ja) 2005-12-08
EP1525198B1 (fr) 2005-12-07
MXPA05000822A (es) 2005-08-29
DK1525198T3 (da) 2006-04-18
CA2492224A1 (en) 2004-01-29
PL375309A1 (en) 2005-11-28
HK1074444A1 (en) 2005-11-11
ZA200500478B (en) 2006-07-26
EP1525198A2 (fr) 2005-04-27
AR040571A1 (es) 2005-04-13
US7202267B2 (en) 2007-04-10
CN100425608C (zh) 2008-10-15
US20050192335A1 (en) 2005-09-01
UA78805C2 (en) 2007-04-25
FR2842527A1 (fr) 2004-01-23
TWI274751B (en) 2007-03-01
BR0312800A (pt) 2005-04-19
ATE312092T1 (de) 2005-12-15
IS2487B (is) 2008-12-15
EA008444B1 (ru) 2007-06-29
IL165942A0 (en) 2006-01-15
ES2254962T3 (es) 2006-06-16
EA200500032A1 (ru) 2005-08-25
AU2003271815B8 (en) 2009-04-30
NO20050292L (no) 2005-04-19
FR2842527B1 (fr) 2005-01-28
HRP20041231A2 (en) 2005-02-28
WO2004009585A3 (fr) 2004-05-06
WO2004009585A2 (fr) 2004-01-29
DE60302670D1 (de) 2006-01-12

Similar Documents

Publication Publication Date Title
IS2602B (is) Púrín efnasambönd og notkun þeirra sem kannabínóíð viðtakabindlar
IS7749A (is) Pýrimídínafleiður og notkun þeirra sem CB2 beina
NO20051360L (no) Gjenget rørskjøt
NO20031285D0 (no) Isolasjons-omlöps-overgangsskjöt
DK1463759T3 (da) Ligand for den G-proteinkoblede receptor GPR43 og anvendelser deraf
DE50206094D1 (de) Substituierte isoindole und ihre verwendung
DE60234984D1 (de) Trid gegenstand
IS2314B (is) Amínóþíasól afleiður og notkun þeirra sem CRF viðtaka bindlar
ATE399056T1 (de) Monocyclopentadienylkomplexe
EP1492191A4 (en) SWIVEL
IS6752A (is) Afleiður tryptamíns og hliðstæð efnasambönd ásamtlyfjaforskriftum þeirra
DE50202730D1 (de) Substituierte isoindole und ihre verwendung
GB2394491B (en) Joining of tubulars through the use of explosives
DE50306340D1 (de) Falzapparat
AU2003232993A8 (en) Drywall tape and joint
ZA200500478B (en) Acyloxypyrrolidine derivatives and use thereof as ligands of V1B or both V1B and V1A receptors
FI20021675A0 (fi) Levityslaite
IS2700B (is) Indól nytsamleg við meðhöndlun á andrógen-viðtaka tengdum sjúkdómum
FI20020524L (fi) Hihnayksikkö ripustimen kiinnittämiseksi kannettaviin laitteisiin
AU2003295881A8 (en) Lamps as modifiers of the p53 pathway and methods of use
DE60301601D1 (de) Falzapparat
GB2415452B (en) Joining of tubulars through the use of explosives
FR2849358B1 (fr) Table suspendue
TW563768U (en) Quick joint structure
ITMT20020003A1 (it) Giunto multidiametro polifunzionale